Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glioblastoma and its treatment are associated with extensive accelerated brain aging

ABSTRACT: Glioblastoma and its treatment are associated with extensive accelerated brain aging

PROVIDER: PRJNA857283 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20068137.fastq.gz	Fastqsanger.gz
	SRR20068138.fastq.gz	Fastqsanger.gz
	SRR20068139.fastq.gz	Fastqsanger.gz
	SRR20068140.fastq.gz	Fastqsanger.gz
	SRR20068141.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 35

Similar Datasets

Glioblastoma and its treatment are associated with extensive accelerated brain aging

Project description:Neurocognitive dysfunction is the leading cause of a reduced quality of life in patients with primary brain tumors. However, how the human brain responds to the tumor and its treatment remains largely unknown. Here we show that the brain of patients with glioblastoma shares features with Alzheimer’s disease and displays hallmarks of accelerated ageing, mitochondrial and neuronal dysfunction, and proteostasis deregulation, thus revealing new targets for managing cancer-related side effects.

2024-03-20 | GSE207821 | GEO

Glioblastoma and its treatment are associated with extensive accelerated brain aging.

Project description:Progressive neurocognitive dysfunction is the leading cause of a reduced quality of life in patients with primary brain tumors. Understanding how the human brain responds to cancer and its treatment is essential to improve the associated cognitive sequelae. In this study, we performed integrated transcriptomic and tissue analysis on postmortem normal-appearing non-tumor brain tissue from glioblastoma (GBM) patients that had received cancer treatments, region-matched brain tissue from unaffected control individuals and Alzheimer's disease (AD) patients. We show that normal-appearing non-tumor brain regions of patients with GBM display hallmarks of accelerated aging, in particular mitochondrial dysfunction, inflammation, and proteostasis deregulation. The extent and spatial pattern of this response decreased with distance from the tumor. Gene set enrichment analyses and a direct comparative analysis with an independent cohort of brain tissue samples from AD patients revealed a significant overlap in differentially expressed genes and a similar biological aging trajectory. Additionally, these responses were validated at the protein level showing the presence of increased lysosomal lipofuscin, phosphorylated microtubule-associated protein Tau, and oxidative DNA damage in normal-appearing brain areas of GBM patients. Overall, our data show that the brain of GBM patients undergoes accelerated aging and shared AD-like features, providing the basis for novel or repurposed therapeutic targets for managing brain tumor-related side effects.

| S-EPMC10928584 | biostudies-literature

Stress induced accelerated aging in mouse eye

Project description:Stress induced accelerated aging in mouse eye

| PRJNA874435 | ENA

Targeting NAT10 enhances healthspan and lifespan in a mouse model of human accelerated aging syndrome.

Project description:Targeting NAT10 enhances healthspan and lifespan in a mouse model of human accelerated aging syndrome.

2018-03-22 | E-MTAB-6578 | biostudies-arrayexpress

Accelerated Midlife Endocrine and Bioenergetic Brain Aging in APOE4 Female Mice

Project description:Accelerated Midlife Endocrine and Bioenergetic Brain Aging in APOE4 Female Mice

| PRJNA1186811 | ENA

HMC3-Progerin cells model for accelerated aging

Project description:HMC3-Progerin cells model for accelerated aging through inducible progerin expression

| PRJEB81801 | ENA

Unraveling Genotypic Proteomic Shifts in Salvia hispanica Seeds Exposed to Accelerated Aging

Project description:This Project investigates the impact of elevated temperatures and relative humidity on the aging process of chia seeds (Salvia hispanica L.). The study employs proteomics to examine molecular responses to accelerated aging in two chia genotypes. The results underscore the importance of evaluating changes in proteins of aged seeds to gain insights into the biological mechanisms responsible for maintaining chia seed integrity during the aging process.

2024-08-06 | PXD049229 | Pride

NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome

Project description:Metabolic dysfunction is a primary feature of Werner syndrome (WS), a human premature aging disease caused by mutations in the gene encoding the Werner (WRN) DNA helicase. WS patients exhibit severe metabolic phenotypes, but the underlying mechanisms are not understood, and whether the metabolic deficit can be targeted for therapeutic intervention has not been determined. Here we report impaired mitophagy and depletion of NAD+, a fundamental ubiquitous molecule, in WS patient samples and WS invertebrate models. WRN regulates transcription of a key NAD+ biosynthetic enzyme nicotinamide nucleotide adenylyltransferase 1 (NMNAT1). NAD+ repletion restores NAD+ metabolic profiles and improves mitochondrial quality through DCT-1 and ULK-1-dependent mitophagy. At the organismal level, NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in C. elegans and Drosophila melanogaster models of WS. Our findings suggest that accelerated aging in WRN syndrome is mediated by impaired mitochondrial function and mitophagy, and that bolstering cellular NAD+ levels counteracts WS phenotypes.

2020-01-13 | PXD015644 | Pride

Mechanisms of Aging in Senescence-Accelerated Mice

Project description:Background: Progressive neurological dysfunction is a key aspect of human aging. Because of underlying differences in the aging of mice and humans, useful mouse models have been difficult to obtain and study. We have used gene-expression analysis and polymorphism screening to study molecular senescence of the retina and hippocampus in two rare inbred mouse models of accelerated neurological senescence (SAMP8 and SAMP10) that closely mimic human neurological aging, and in a related normal strain (SAMR1) and an unrelated normal strain (C57BL/6J). Results: The majority of age-related gene expression changes were strain-specific, with only a few common pathways found for normal and accelerated neurological aging. Polymorphism screening led to the identification of mutations that could have a direct impact on important disease processes, including a mutation in a fibroblast growth factor gene, Fgf1, and a mutation in and ectopic expression of the gene for the chemokine CCL19, which is involved in the inflammatory response. Conclusions: We show that combining the study of inbred mouse strains with interesting traits and gene-expression profiling can lead to the discovery of genes important for complex phenotypes. Furthermore, full-genome polymorphism detection, sequencing and gene-expression profiling of inbred mouse strains with interesting phenotypic differences may provide unique insights into the molecular genetics of late-manifesting complex diseases. Keywords: disease state analysis

2007-01-24 | GSE6238 | GEO

Stress induced accelerated aging in mouse eye [ATAC-seq]

Project description:Stress induced accelerated aging in mouse eye [ATAC-seq]

| PRJNA874436 | ENA